Atossa Therapeutics Stock (NASDAQ: ATOS) stock price, news, charts, stock research, profile.
Open | $1.45 |
Close | - |
Volume / Avg. | 144.19K / 999.53K |
Day Range | $1.43 - $1.49 |
52 Wk Range | 0.62 - 2.31 |
Market Cap | $184.86M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 10.26% |
Days to Cover | 23.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.
Other companies in Atossa Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA) and Skye Bioscience (NASDAQ:SKYE).
Atossa Therapeutics has a consensus price target of $6.25.
The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $1.47 last updated September 19, 2024 at 11:09 AM EDT.
There are no upcoming dividends for Atossa Therapeutics.
Atossa Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Atossa Therapeutics.
Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.